VRPX
Virpax Pharmaceuticals, Inc. - Common Stock (VRPX)
$02
About Virpax Pharmaceuticals, Inc. - Common Stock (VRPX)
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Details
Daily high
$0.02
Daily low
$0.02
Price at open
$0.02
52 Week High
$12.88
52 Week Low
$0.01
Market cap
26,100
Dividend yield
0.00%
Volume
769
Avg. volume
1,476
P/E ratio
.00
Virpax Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$0.02
Daily low
$0.02
Price at open
$0.02
52 Week High
$12.88
52 Week Low
$0.01
Market cap
26,100
Dividend yield
0.00%
Volume
769
Avg. volume
1,476
P/E ratio
.00